dr. gomella on enzalutamide in prostate cancer
Published 6 years ago • 556 plays • Length 0:44Download video MP4
Download video MP3
Similar videos
-
0:57
dr. gomella on immunotherapy developments in prostate cancer
-
0:51
dr. gomella on the fda approval of enzalutamide in nonmetastatic crpc
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
1:11
dr. gomella discusses precision medicine in prostate cancer
-
1:11
dr. gomella on the evolution of ar inhibitors in prostate cancer
-
7:00
comparing the second generation hormone therapies | ask a prostate expert, mark scholz, md
-
3:25
life expectancy with prostate cancer diagnosis
-
6:37
advancing localized prostate cancer treatment: effects of apalutamide, adt
-
1:10
dr. gomella on the fda approval of apalutamide for nonmetastatic crpc
-
0:53
dr. freedland on real-world utility of enzalutamide in prostate cancer
-
1:13
dr. gomella on labeling low-risk prostate cancer
-
0:54
dr. gomella on potential impact of targeted therapy approvals on genetic testing in prostate cancer
-
1:27
dr. gomella on screening recommendations in prostate cancer
-
1:09
dr. gomella on challenges facing genetic testing in prostate cancer
-
1:24
dr. gomella on the prevalence of genetic testing in prostate cancer
-
1:06
dr. bradley on adverse events associated with enzalutamide and apalutamide in prostate cancer
-
1:22
dr. gomella on the evolution of genetic testing in prostate cancer
-
1:47
dr. hussain on potential of enzalutamide in prostate cancer
-
1:01
dr. leonard gomella on sequencing prostate cancer therapies
-
8:09
comparing apalutamide and enzalutamide in real-world treatment of mcspc
-
1:09
dr. gomella on the challenges of genetic testing in prostate cancer
-
1:37
dr. gomella on the state of genetic testing and screening in prostate cancer